Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,870 Million (Small Cap)
28.00
NA
0.00%
0.26
15.73%
4.33
Revenue and Profits:
Net Sales:
244 Million
(Quarterly Results - Mar 2026)
Net Profit:
66 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.76%
0%
2.76%
6 Months
-19.23%
0%
-19.23%
1 Year
-2.86%
0%
-2.86%
2 Years
93.62%
0%
93.62%
3 Years
57.11%
0%
57.11%
4 Years
121.76%
0%
121.76%
5 Years
39.84%
0%
39.84%
Cheng Du Sheng Nuo Biotec Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.88%
EBIT Growth (5y)
52.23%
EBIT to Interest (avg)
6.55
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
0.32
Sales to Capital Employed (avg)
0.39
Tax Ratio
17.66%
Dividend Payout Ratio
25.04%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.26%
ROE (avg)
9.15%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
4.33
EV to EBIT
22.39
EV to EBITDA
18.63
EV to Capital Employed
3.65
EV to Sales
6.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.29%
ROE (Latest)
15.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
244.30
184.30
32.56%
Operating Profit (PBDIT) excl Other Income
79.10
68.50
15.47%
Interest
6.50
3.30
96.97%
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
66.40
47.10
40.98%
Operating Profit Margin (Excl OI)
323.70%
310.90%
1.28%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 32.56% vs 77.04% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 40.98% vs 185.45% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
739.90
454.40
62.83%
Operating Profit (PBDIT) excl Other Income
267.30
101.10
164.39%
Interest
17.70
12.00
47.50%
Exceptional Items
0.20
0.30
-33.33%
Consolidate Net Profit
157.90
49.80
217.07%
Operating Profit Margin (Excl OI)
283.20%
144.20%
13.90%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 62.83% vs 5.43% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 217.07% vs -29.16% in Dec 2024
About Cheng Du Sheng Nuo Biotec Co., Ltd. 
Cheng Du Sheng Nuo Biotec Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






